Wells Fargo & Company Liquidia Corp Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Liquidia Corp stock. As of the latest transaction made, Wells Fargo & Company holds 17,753 shares of LQDA stock, worth $209,485. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,753

Previous 23,455 24.31%

Holding current value

$209,485

Previous $281,000 37.01%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$8.9 - $14.11 $50,747 - $80,455	-5,702 Reduced 24.31%	17,753 $177,000
Q2 2024 Aug 13, 2024	BUY	$11.96 - $15.71 $81,244 - $106,718	6,793 Added 40.77%	23,455 $281,000
Q1 2024 May 10, 2024	BUY	$11.35 - $16.73 $34,980 - $51,561	3,082 Added 22.7%	16,662 $245,000
Q4 2023 Feb 09, 2024	BUY	$5.77 - $12.19 $18,614 - $39,324	3,226 Added 31.16%	13,580 $163,000
Q3 2023 Nov 13, 2023	SELL	$6.27 - $8.15 $56,116 - $72,942	-8,950 Reduced 46.36%	10,354 $65,000
Q2 2023 Aug 15, 2023	BUY	$6.63 - $9.9 $68,633 - $102,484	10,352 Added 115.64%	19,304 $151,000
Q1 2023 May 12, 2023	BUY	$5.72 - $7.91 $51,205 - $70,810	8,952 New	8,952 $61,000
Q3 2022 Nov 14, 2022	SELL	$3.73 - $8.39 $1,883 - $4,236	-505 Reduced 45.83%	597 $3,000
Q2 2022 Aug 12, 2022	SELL	$3.37 - $7.55 $82,854 - $185,624	-24,586 Reduced 95.71%	1,102 $5,000
Q1 2022 May 16, 2022	BUY	$5.14 - $7.38 $117,860 - $169,223	22,930 Added 831.4%	25,688 $185,000
Q4 2021 Feb 14, 2022	BUY	$2.71 - $5.17 $6,775 - $12,925	2,500 Added 968.99%	2,758 $13,000
Q3 2021 Nov 15, 2021	BUY	$2.28 - $2.95 $38 - $50	17 Added 7.05%	258 $1,000
Q2 2021 Aug 16, 2021	SELL	$2.51 - $3.11 $21,646 - $26,820	-8,624 Reduced 97.28%	241 $1,000
Q1 2021 May 13, 2021	SELL	$2.42 - $3.6 $105,608 - $157,104	-43,640 Reduced 83.12%	8,865 $24,000
Q4 2020 Feb 09, 2021	BUY	$2.6 - $5.79 $40,024 - $89,131	15,394 Added 41.48%	52,505 $154,000
Q3 2020 Nov 05, 2020	BUY	$4.34 - $8.28 $6,162 - $11,757	1,420 Added 3.98%	37,111 $183,000
Q2 2020 Aug 13, 2020	BUY	$4.86 - $11.44 $96,330 - $226,752	19,821 Added 124.9%	35,691 $300,000
Q1 2020 May 14, 2020	BUY	$3.31 - $7.15 $52,529 - $113,470	15,870 New	15,870 $75,000

Others Institutions Holding LQDA

# of Institutions

171

Shares Held

44.3M

Call Options Held

1.55M

Put Options Held

1.52M

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $759M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Liquidia Corp Transaction History